CBD-Intel

CBD in Brazil

Brazil is the largest country in South America and although it has strict regulations, developments suggest positive steps for the industry. This page includes all of our detailed full-length Brazilian market and regulatory reports, as well as both business and regulatory briefings covering current updates from the country.

Nearly 80% of Brazil’s population have said they are in favour of using cannabis for medical purposes. Yet a bill to legalise the cultivation and processing of hemp and medical cannabis in Brazil that passed an important committee vote in the country’s lower legislative chamber hit a hurdle when the Brazilian lower house, the Chamber of Deputies, requested a meeting of the full chamber.

Our legal analysts keep an eye on daily developments to keep you informed of developments.

Find out which proposals are currently in discussion that are likely to change the law in future, plus which political attitudes are driving new regulation and how they will impact your business. 

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions